Slate Bio
About:
Slate Bio is an immunotherapeutics development company that develops therapeutic solutions for autoimmune diseases.
Website: https://slatebio.com
Top Investors: Epidarex Capital, Virginia Venture Partners, UVA Licensing & Ventures Group, PharmaDirections, VTC Seed Fund
Description:
Slate Bio is an immunotherapeutics development company that develops therapies that restore the body's natural immunological response in different diseases using bifunctional IL233 cytokine, thereby providing users with an independent synergistic pathway that has greater tissue selectivity and improved pharmacodynamics.
$4.53M
$1M to $10M
Charlottesville, Virginia, United States
2020-01-01
info(AT)slatebio.com
1-10
2023-01-17
Private
© 2025 bioDAO.ai